OBJECTIVE: Despite increased physician's awareness and improved diagnostic and serological testing in the recent years, the interval between the initial symptoms and the diagnosis of Systemic lupus erythematosus (SLE) is still very long. Our aim was to study this delay and its association to the outcome of the disease. METHODS: Information on demographics, onset of first symptoms, first physicians visit and time of diagnosis was assessed by self-reported questionnaires among SLE patients in Germany (LuLa cohort, n = 585) in the year 2012. Disease activity (Systemic Lupus Activity Questionnaire; SLAQ), disease related damage (Brief Index of Lupus Damage; BILD), health related quality of life (Short Form 12) and fatigue (FSS) were chosen as proxies for outcome. Linear regression analysis was used to analyze the association of the delay in diagnosis to the outcome, adjusted for age, disease duration and sex. RESULTS: Mean duration between the onset of symptoms and the diagnosis of SLE was 47 months (SD 73). The longer the time to diagnosis, the higher the disease activity (β = 0.199, p < 0.0001), the disease-related damage (β = 0.137, p = 0.002) and fatigue (β 0.145, p = 0.003) and the lower the health-related quality of life (physical β = -0.136, p = 0.004, mental β = -0.143, p = 0.004). CONCLUSION: In systemic lupus erythematosus, longer time to diagnosis was associated with worse outcome. Concepts in care with the intention to shorten the time to diagnosis are needed to improve the long-term outcome of the disease.
OBJECTIVE: Despite increased physician's awareness and improved diagnostic and serological testing in the recent years, the interval between the initial symptoms and the diagnosis of Systemic lupus erythematosus (SLE) is still very long. Our aim was to study this delay and its association to the outcome of the disease. METHODS: Information on demographics, onset of first symptoms, first physicians visit and time of diagnosis was assessed by self-reported questionnaires among SLEpatients in Germany (LuLa cohort, n = 585) in the year 2012. Disease activity (Systemic Lupus Activity Questionnaire; SLAQ), disease related damage (Brief Index of Lupus Damage; BILD), health related quality of life (Short Form 12) and fatigue (FSS) were chosen as proxies for outcome. Linear regression analysis was used to analyze the association of the delay in diagnosis to the outcome, adjusted for age, disease duration and sex. RESULTS: Mean duration between the onset of symptoms and the diagnosis of SLE was 47 months (SD 73). The longer the time to diagnosis, the higher the disease activity (β = 0.199, p < 0.0001), the disease-related damage (β = 0.137, p = 0.002) and fatigue (β 0.145, p = 0.003) and the lower the health-related quality of life (physical β = -0.136, p = 0.004, mental β = -0.143, p = 0.004). CONCLUSION: In systemic lupus erythematosus, longer time to diagnosis was associated with worse outcome. Concepts in care with the intention to shorten the time to diagnosis are needed to improve the long-term outcome of the disease.
Authors: Frances Rees; Michael Doherty; Peter Lanyon; Graham Davenport; Richard D Riley; Weiya Zhang; Matthew J Grainge Journal: Arthritis Care Res (Hoboken) Date: 2017-05-08 Impact factor: 4.794
Authors: Natasja J H Raijmakers; M Zijlstra; J van Roij; O Husson; S Oerlemans; L V van de Poll-Franse Journal: Support Care Cancer Date: 2018-04-16 Impact factor: 3.603
Authors: Alan Oglesby; Caroline Korves; François Laliberté; Gregory Dennis; Sapna Rao; Ellison Dial Suthoff; Robert Wei; Mei Sheng Duh Journal: Appl Health Econ Health Policy Date: 2014-04 Impact factor: 2.561
Authors: E W Karlson; L H Daltroy; C Rivest; R Ramsey-Goldman; E A Wright; A J Partridge; M H Liang; P R Fortin Journal: Lupus Date: 2003 Impact factor: 2.911
Authors: Melanie Sloan; Rupert Harwood; Stephen Sutton; David D'Cruz; Paul Howard; Chris Wincup; James Brimicombe; Caroline Gordon Journal: Rheumatol Adv Pract Date: 2020-02-26
Authors: Mishal F Karremah; Rola Y Hassan; Ammar Z Faloudah; Lujain K Alharbi; Albraa F Shodari; Ahmad A Rahbeeni; Nouf K Alharazi; Ahmad Z Binjabi; Mohamed M Cheikh; Hanadi Manasfi; Sultana Abdulaziz; Albadr Hamza Hussein; Ahmed Alhazmi; Hani Almoallim Journal: Open Access Rheumatol Date: 2022-06-29